New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
[ad_1] The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from
Read More[ad_1] The approval of two gene therapies to treat sickle cell disease has given hope to patients who suffer from
Read More[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin
Read More[ad_1] Ark Invest’s Cathie Wood unveiled her highest conviction stock picks for 2024 as she winds down a banner year
Read More[ad_1] Check out the companies making headlines in midday trading. Etsy — Etsy’s stock sank 5% after the e-commerce company
Read More